Human Umbilical Cord Blood Infusion Improves Fatigue in Long-COVID

Summary: StemCyte announced phase IIa clinical trial results for RegeneCyte (HPC, cord blood) in treating post-COVID syndrome, with 85% of patients experiencing complete relief from fatigue symptoms compared to 20% in the placebo group. The trial, involving 30 participants, met its primary and secondary endpoints, demonstrating both safety and efficacy. The treatment significantly reduced fatigue…

Read More

ŌURA Raises $200M to Fuel Wearable Health Tech

Summary: ŌURA, the company behind the Oura Ring, completed a $200 million Series D funding round, raising its valuation to $5.2 billion. The funding will support product expansion, healthcare innovation—including artificial intelligence—global growth, and potential acquisitions. The funding comes after a year in which ŌURA reported higher sales, expanded its retail and commercial partnerships, and…

Read More

Plant-Based Sleep Ingredient Somato Earns Alkemist Assured Quality Seal

Summary: Nutraland USA’s Somato, a tomato-derived, plant-based sleep ingredient, has received the Alkemist Assured certification through Alkemist Labs’ quality transparency program. The certification verifies the ingredient’s authenticity, purity, and adherence to quality standards. Somato is designed to provide a natural alternative to synthetic melatonin, containing compounds like Lycopene and GABA. Key Takeaways: Certification Achievement: Nutraland…

Read More